Medtronic (MDT) Receives FDA Approval of Attain Performa LV Quadripolar Leads
Tweet Send to a Friend
Medtronic (NYSE: MDT) announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
